Expectations trend
FY2028 · fiscal year ending 2028-06-30 · fmp
PALATIN TECHNOLOGIES INC (PTN)
NASDAQHealth CareBiotechnologySnapshot 2026-11-04
$5.71-5.15%
Close 2026-11-05 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
Matching fiscal periods, usable estimates and at least one analyst are required.
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
The calculation requires same-period, same-provider snapshots, positive EPS, at least one analyst and a baseline within three days of the requested lookback.
The EPS and P/E reference is not available for PTN yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
4 published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Reduce negative cash from operations | A supporting condition in PALATIN TECHNOLOGIES INC's published investment case. The stated target is cash from operations >= -$4.4 million. | Improving | cash from operations worsens beyond -$5 million in 2026-Q3 | Cash from operations: $-2.69M FY2026-Q4; GAAP. Published target: cash from operations >= -$4.4 million. The stored target says 2026-Q3; this source reports FY2026-Q4. Fiscal/calendar alignment needs review. Sep 28, 2026-2,689,980 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
FY2028 · fiscal year ending 2028-06-30 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Nov 13, 2026
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
PTN is a high-risk, small-cap business with an improvement-driven thesis, rather than a proven durable compounder. The thesis is currently intact, though its signal has shifted from mildly favorable to mixed and earnings quality remains fragile.
The evidence describes PTN as cheap versus peers, while the model has low confidence and the expectations gap is negative. The weakness priced in appears limited to poor execution quality, rather than a full combination of expensive valuation, weak execution, and turbulence.
Near term, an earnings miss is a meaningful risk given erratic recent surprises. Revenue has varied sharply across recent quarters, while operating losses narrowed by 2026-Q3; operating cash flow remained negative. Management has kept revenue growth and profitability as priorities, but cash management progress is mixed.
Over the next few quarters, the thesis hinges on steadier revenue, continued progress toward lower operating losses, and better cash flow. A guidance cut or further weakness in employment data would add risk, while stronger results and guidance from healthcare sector bellwethers could support sector momentum.
For the next 1 to 3 years, PTN offers a cheap-versus-peers valuation alongside fragile execution and high risk, so the thesis depends on whether operational progress becomes more consistent. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Stated as a priority in 3 of last 3 quarters. Cash from operating activities remained negative, with -$1.6M in 2026-Q1 worsening to -$4.8M in 2026-Q2 and -$4.4M in 2026-Q3. Operating losses narrowed in recent quarters, indicating some cost control but cash flow remains negative, showing limited progress.
Delivery assessment Aug 16, 2026Complete transfer to Nasdaq Capital Market | The company has new partnerships and a Nasdaq listing plan. | Improving | listing transfer not completed by end 2026-Q3 | Transfer initiated 2026-05-18 vs 2026-Q3 target Notice of voluntary withdrawal from NYSE and transfer to Nasdaq Capital Market filed on May 18, 2026. Nov 4, 2026Last status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextNewly stated in 2026-Q3. Management announced the intent to voluntarily withdraw the listing from NYSE American and transfer to Nasdaq Capital Market. This is a one-time regulatory event with no financial metrics to track progress in the data. Delivery assessment Aug 16, 2026 |
Narrow operating losses | A primary condition in PALATIN TECHNOLOGIES INC's published investment case. The stated target is operating loss <= -$1.58 million. | Improving | operating loss worsens beyond -$2 million in 2026-Q3 | Operating income: $-4.42M FY2026-Q4; GAAP. Published target: operating loss <= -$1.58 million. The stored target says 2026-Q3; this source reports FY2026-Q4. Fiscal/calendar alignment needs review. Sep 28, 2026-4,419,799 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated as a priority in 3 of last 3 quarters. Revenue was $8.83M in 2026-Q1 and 2026-Q3 but dropped to $116K in 2026-Q2. Operating income improved from a loss of $7.3M in 2026-Q2 to a loss of $1.58M in 2026-Q3. The trajectory shows some volatility but recent quarters indicate progress toward improving profitability. Delivery assessment Aug 16, 2026 |
Grow revenue from low levels | A primary condition in PALATIN TECHNOLOGIES INC's published investment case. The stated target is >= $8.83 million. | Intact | revenue falls below $8 million in 2026-Q3 | Revenue: $300,770 FY2026-Q4; GAAP. Published target: >= $8.83 million. The stored target says 2026-Q3; this source reports FY2026-Q4. Fiscal/calendar alignment needs review. Sep 28, 2026300,770 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated as a priority in 3 of last 3 quarters. Revenue was $8.83M in 2026-Q1 and 2026-Q3 but dropped to $116K in 2026-Q2. Operating income improved from a loss of $7.3M in 2026-Q2 to a loss of $1.58M in 2026-Q3. The trajectory shows some volatility but recent quarters indicate progress toward improving profitability. Delivery assessment Aug 16, 2026 |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$-3.17 → $-2.13 · observed estimates
$0.00B → $0.01B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-07-24 | $-3.17 | $4,833,333 | 1 / 1 |
| 2026-07-25 | $-3.17 | $4,833,333 | 1 / 1 |
| 2026-07-26 | $-3.17 | $4,833,333 | 1 / 1 |
| 2026-07-27 | $-3.17 | $4,833,333 | 1 / 1 |
| 2026-07-28 | $-3.17 | $4,833,333 | 1 / 1 |
| 2026-07-29 | $-3.17 | $4,833,333 | 1 / 1 |
| 2026-07-30 | $-3.17 | $4,833,333 | 1 / 1 |
| 2026-07-31 | $-3.17 | $4,833,333 | 1 / 1 |
| 2026-08-01 | $-3.17 | $4,833,333 | 1 / 1 |
| 2026-08-02 | $-3.17 | $4,833,333 | 1 / 1 |
| 2026-08-03 | $-3.17 | $4,833,333 | 1 / 1 |
| 2026-08-04 | $-3.17 | $4,833,333 | 1 / 1 |
| 2026-08-05 | $-3.17 | $4,833,333 | 1 / 1 |
| 2026-08-06 | $-3.17 | $4,833,333 | 1 / 1 |
| 2026-08-07 | $-3.17 | $4,833,333 | 1 / 1 |
| 2026-08-08 | $-3.17 | $4,833,333 | 1 / 1 |
| 2026-08-09 | $-3.17 | $4,833,333 | 1 / 1 |
| 2026-08-10 | $-3.17 | $4,833,333 | 1 / 1 |
| 2026-08-12 | $-3.17 | $4,833,333 | 1 / 1 |
| 2026-08-13 | $-3.17 | $4,833,333 | 1 / 1 |
| 2026-08-14 | $-3.17 | $4,833,333 | 1 / 1 |
| 2026-08-15 | $-3.17 | $4,833,333 | 1 / 1 |
| 2026-08-16 | $-3.17 | $4,833,333 | 1 / 1 |
| 2026-08-17 | $-3.17 | $4,833,333 | 1 / 1 |
| 2026-08-18 | $-3.17 | $4,833,333 | 1 / 1 |
| 2026-08-19 | $-3.17 | $4,833,333 | 1 / 1 |
| 2026-08-20 | $-3.17 | $4,833,333 | 1 / 1 |
| 2026-08-21 | $-3.17 | $4,833,333 | 1 / 1 |
| 2026-08-22 | $-3.17 | $4,833,333 | 1 / 1 |
| 2026-08-23 | $-3.17 | $4,833,333 | 1 / 1 |
| 2026-08-24 | $-3.17 | $4,833,333 | 1 / 1 |
| 2026-08-25 | $-3.17 | $4,833,333 | 1 / 1 |
| 2026-08-26 | $-3.17 | $4,833,333 | 1 / 1 |
| 2026-08-27 | $-3.17 | $4,833,333 | 1 / 1 |
| 2026-08-28 | $-3.17 | $4,833,333 | 1 / 1 |
| 2026-08-29 | $-3.17 | $4,833,333 | 1 / 1 |
| 2026-08-30 | $-3.17 | $4,833,333 | 1 / 1 |
| 2026-08-31 | $-3.17 | $4,833,333 | 1 / 1 |
| 2026-09-01 | $-3.17 | $4,833,333 | 1 / 1 |
| 2026-09-02 | $-3.17 | $4,833,333 | 1 / 1 |
| 2026-09-03 | $-3.17 | $4,833,333 | 1 / 1 |
| 2026-09-04 | $-3.17 | $4,833,333 | 1 / 1 |
| 2026-09-05 | $-3.17 | $4,833,333 | 1 / 1 |
| 2026-09-06 | $-3.17 | $4,833,333 | 1 / 1 |
| 2026-09-07 | $-3.17 | $4,833,333 | 1 / 1 |
| 2026-09-08 | $-3.17 | $4,833,333 | 1 / 1 |
| 2026-09-09 | $-3.17 | $4,833,333 | 1 / 1 |
| 2026-09-10 | $-3.17 | $4,833,333 | 1 / 1 |
| 2026-09-11 | $-3.17 | $4,833,333 | 1 / 1 |
| 2026-09-12 | $-3.17 | $4,833,333 | 1 / 1 |
| 2026-09-13 | $-3.17 | $4,833,333 | 1 / 1 |
| 2026-09-14 | $-3.17 | $4,833,333 | 1 / 1 |
| 2026-09-15 | $-3.17 | $4,833,333 | 1 / 1 |
| 2026-09-16 | $-3.17 | $4,833,333 | 1 / 1 |
| 2026-09-17 | $-3.17 | $4,833,333 | 1 / 1 |
| 2026-09-18 | $-3.17 | $4,833,333 | 1 / 1 |
| 2026-09-19 | $-3.17 | $4,833,333 | 1 / 1 |
| 2026-09-20 | $-3.17 | $4,833,333 | 1 / 1 |
| 2026-09-21 | $-3.17 | $4,833,333 | 1 / 1 |
| 2026-09-22 | $-3.17 | $4,833,333 | 1 / 1 |
| 2026-09-23 | $-3.17 | $4,833,333 | 1 / 1 |
| 2026-09-24 | $-3.17 | $4,833,333 | 1 / 1 |
| 2026-09-25 | $-3.17 | $4,833,333 | 1 / 1 |
| 2026-09-26 | $-3.17 | $4,833,333 | 1 / 1 |
| 2026-09-27 | $-3.17 | $4,833,333 | 1 / 1 |
| 2026-09-28 | $-3.17 | $4,833,333 | 1 / 1 |
| 2026-09-29 | $-2.46 | $6,000,000 | 2 / 3 |
| 2026-09-30 | $-2.56 | $6,000,000 | 2 / 3 |
| 2026-10-01 | $-2.13 | $7,333,333 | 2 / 3 |
| 2026-10-02 | $-2.13 | $7,333,333 | 2 / 3 |
| 2026-10-03 | $-2.13 | $7,333,333 | 2 / 3 |
| 2026-10-04 | $-2.13 | $7,333,333 | 2 / 3 |
| 2026-10-05 | $-2.13 | $7,333,333 | 2 / 3 |
| 2026-10-06 | $-2.13 | $7,333,333 | 2 / 3 |
| 2026-10-07 | $-2.13 | $7,333,333 | 2 / 3 |
| 2026-10-08 | $-2.13 | $7,333,333 | 2 / 3 |
| 2026-10-09 | $-2.13 | $7,333,333 | 2 / 3 |
| 2026-10-10 | $-2.13 | $7,333,333 | 2 / 3 |
| 2026-10-11 | $-2.13 | $7,333,333 | 2 / 3 |
| 2026-10-12 | $-2.13 | $7,333,333 | 2 / 3 |
| 2026-10-13 | $-2.13 | $7,333,333 | 2 / 3 |
| 2026-10-14 | $-2.13 | $7,333,333 | 2 / 3 |
| 2026-10-15 | $-2.13 | $7,333,333 | 2 / 3 |
| 2026-10-16 | $-2.13 | $7,333,333 | 2 / 3 |
| 2026-10-17 | $-2.13 | $7,333,333 | 2 / 3 |
| 2026-10-18 | $-2.13 | $7,333,333 | 2 / 3 |
| 2026-10-19 | $-2.13 | $7,333,333 | 2 / 3 |
| 2026-10-20 | $-2.13 | $7,333,333 | 2 / 3 |
| 2026-10-21 | $-2.13 | $7,333,333 | 2 / 3 |
| 2026-10-22 | $-2.13 | $7,333,333 | 2 / 3 |
| 2026-10-23 | $-2.13 | $7,333,333 | 2 / 3 |
| 2026-10-24 | $-2.13 | $7,333,333 | 2 / 3 |
| 2026-10-25 | $-2.13 | $7,333,333 | 2 / 3 |
| 2026-10-26 | $-2.13 | $7,333,333 | 2 / 3 |
| 2026-10-27 | $-2.13 | $7,333,333 | 2 / 3 |
| 2026-10-28 | $-2.13 | $7,333,333 | 2 / 3 |
| 2026-10-29 | $-2.13 | $7,333,333 | 2 / 3 |
| 2026-10-30 | $-2.13 | $7,333,333 | 2 / 3 |
| 2026-10-31 | $-2.13 | $7,333,333 | 2 / 3 |
| 2026-11-01 | $-2.13 | $7,333,333 | 2 / 3 |
| 2026-11-02 | $-2.13 | $7,333,333 | 2 / 3 |
| 2026-11-03 | $-2.13 | $7,333,333 | 2 / 3 |
| 2026-11-04 | $-2.13 | $7,333,333 | 2 / 3 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 3 Buy / Strong Buy · 0 Hold · 0 Sell / Strong Sell
Recent actions · Oct 6–Nov 4 · 0 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
3 of 4 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.